Cancer Biology Laboratory & DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam, India.
Cancer Biology Laboratory & DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam, India.
Clin Breast Cancer. 2018 Jun;18(3):e393-e399. doi: 10.1016/j.clbc.2017.07.013. Epub 2017 Jul 20.
Breast cancer is the most prevalent cancer among women worldwide. Among the different breast cancer subtypes, triple-negative breast cancer (TNBC), which is more prevalent among younger age women, is the most aggressive form. Numerous clinicopathologic studies performed throughout the world strongly support the utterly poor prognoses and high recurrence rate of TNBC. The present report details a thorough data survey from Google and PubMed on the burden of TNBC worldwide and other associated factors, with special emphasis on its ever increasing incidence among Indian women. Our analysis revealed that the proportion of TNBC ranges from 6.7% to 27.9% in different countries, with the highest reported percentage in India among all, followed by Indonesia, Algeria, and Pakistan. Most of the other countries (Netherlands, Italy, London, Germany) had a TNBC incidence less than the mean level (ie, 15%). The high incidence of TNBC in the Indian population is associated with vivid risk factors, which primarily include lifestyle, deprivation status, obesity, family history, high mitotic indexes, and BRCA1 mutations. The treatment of TNBC is greatly hampered due to the lack of targeted therapies. Hence, it requires earnest attention towards extensive research for the prevention and development of treatment modalities with high efficacy.
乳腺癌是全球女性最常见的癌症。在不同的乳腺癌亚型中,三阴性乳腺癌(TNBC)在年轻女性中更为常见,是最具侵袭性的形式。全球范围内进行的大量临床病理研究强烈支持 TNBC 预后极差和复发率高。本报告详细介绍了全球 TNBC 负担及其他相关因素的谷歌和 PubMed 全面数据调查,特别强调了其在印度女性中发病率不断上升的情况。我们的分析表明,不同国家 TNBC 的比例在 6.7%到 27.9%之间,其中印度的报告比例最高,其次是印度尼西亚、阿尔及利亚和巴基斯坦。大多数其他国家(荷兰、意大利、伦敦、德国)的 TNBC 发病率低于平均水平(即 15%)。印度人群中 TNBC 的高发病率与明显的危险因素有关,主要包括生活方式、贫困状况、肥胖、家族史、高有丝分裂指数和 BRCA1 突变。由于缺乏靶向治疗,TNBC 的治疗受到很大阻碍。因此,需要认真关注广泛的研究,以预防和开发具有高疗效的治疗方法。